Plasma Processes and Cancer - Special Topical Cluster of the 2nd IWPCT Meeting by Hori, Masaru et al.
Old Dominion University
ODU Digital Commons
Electrical & Computer Engineering Faculty
Publications Electrical & Computer Engineering
2015
Plasma Processes and Cancer - Special Topical
Cluster of the 2nd IWPCT Meeting
Masaru Hori
Mounir Laroussi
Old Dominion University, mlarouss@odu.edu
Kai Masur
Yuzuru Ikehara
Follow this and additional works at: https://digitalcommons.odu.edu/ece_fac_pubs
Part of the Biomedical Commons, Fluid Dynamics Commons, and the Polymer Science
Commons
This Editorial is brought to you for free and open access by the Electrical & Computer Engineering at ODU Digital Commons. It has been accepted for
inclusion in Electrical & Computer Engineering Faculty Publications by an authorized administrator of ODU Digital Commons. For more information,
please contact digitalcommons@odu.edu.
Repository Citation
Hori, Masaru; Laroussi, Mounir; Masur, Kai; and Ikehara, Yuzuru, "Plasma Processes and Cancer - Special Topical Cluster of the 2nd
IWPCT Meeting" (2015). Electrical & Computer Engineering Faculty Publications. 187.
https://digitalcommons.odu.edu/ece_fac_pubs/187
Original Publication Citation
Hori, M., Laroussi, M., Masur, K., & Ikehara, Y. (2015). Plasma processes and cancer - special topical cluster of the 2nd IWPCT
meeting. Plasma Processes and Polymers, 12(12), 1336-1337. doi:10.1002/ppap.201500180
Plasma Processes and Cancer – Special Topical
Cluster of the 2nd IWPCT Meeting
Although the emerging multidiscipli-
nary field of plasma medicine has
been around for nearly two decades
important advances have already
taken place that could one day
revolutionize healthcare and the
way various challenging diseases
can be treated.[1–3]Amongst these
advances the effects of low temper-
ature plasma (LTP) on cancer cells in
vitro and in vivo stand out.[4–13]-
Current cancer treatment modalities,
such as chemotherapy and radiation
therapy, have serious side effects and
tend to lose their benefits to the
patients after a while. Therefore,
novel and improved therapies that
can be used alone or in conjunction
with other methods are always
sought after by the medical com-
munity. LTP is proving to be one such
possibility. Mounting experimental
evidence is showing that LTP acts
on cancer cells and tumors via the
reactive oxygen species (ROS) and
reactive nitrogen species (RNS) it
produces. These chemically reactive





strong oxidative properties and/or
trigger signaling pathways in bio-
logical cells that could lead to cell
death by necrosis or apoptosis. In
addition, several investigators have
reported that LTP targets cancer cells
in a selective manner, mostly sparing
their healthy counterparts. This is an
important finding that can play a
crucial role in the acceptance of
plasma technology as a safe and
hopefully successful cancer treat-
ment modality.
In order to offer an opportunity for
researchers investigating the cancer
applications of LTP to meet, present
their latest results, exchange ideas,
and establish collaborations, the
International Workshop on Plasma
for Cancer Treatment (IWPCT) was
established. The first edition of IWPCT
(IWPCT-1) was organized by Profs. M.
Laroussi andM.Keidar andwasheld in
Washington DC in 2014. The second
editionof IWPCT (IWPCT-2)washeld in
Nagoya University in 2015 and was
chaired by Prof. M. Hori. Twenty (20)
invited papers were delivered at this
meeting along with 61 posters pre-
sentations. Researchers hailing from
11 countries attended IWPCT-2, which
allowed for excellent exchange of
ideas and networking opportunities.
Most interestingly two presentations
reporting for the first time on two
clinical/human trials using plasma
jets were presented by Dr. Metelmann
from Germany and Dr. J. Canady from
the USA. The cancers cases thus treated
were head-neck cancers and colorectal
cancer, respectively.
This cluster issue of Plasma Proc-
esses and Polymers contains several
papers that are inspired from the talks
that were given at IWPCT-2. These
papers report on interesting new
developments in the field including
the eradication of melanoma cells
in vivo, the use of LTP synergistically
with a cancer drug to inhibit cancer
cells proliferation, the combination of
LTP and gold nanoparticles to kill
glioblastoma cells, and the use of LTP
to stimulate the immune system to
fight cancer.
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